explore -WSS

explore

author：entertainment 2025-09-27 16:47:44 - browse：874

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： MassMutual is introducing free genetic testing for members

WSS

Bird flu outbreak in cows is latest avian flu curveball

Does aspartame cause cancer? What new WHO guidance says

H5N1 bird flu virus started spreading in cows in Texas in December

Orangutan used medicinal plant to treat wound, first time ever seen

Bird flu in milk supply is likely coming from asymptomatic cows

Eli Lilly to acquire Versanis in heated race for weight loss drugs

entertainment

explore

explore

New air purifier tech could be key to improving indoor air quality

Georgia court denies Trump's request to quash DA's 2020 election probe

Medicare proposal to cover medical devices draws a mixed reaction

Cholera vaccine supply gets boost as demand surges globally

Medicare proposal to cover medical devices draws a mixed reaction

Celiac disease study examines precisely how gluten triggers injury

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congress: Eradicate hepatitis C and reduce the deficit

Medicare proposal to cover medical devices draws a mixed reaction

Cancer researcher Catriona Jamieson is sending tumors into space

entertainment

Grail faces three suits alleging harassment, retaliation

Getting Alzheimer's drug Leqembi to patients can be a challenge

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Close Medicare's dangerous gaps in addiction treatment coverage

Celiac disease study examines precisely how gluten triggers injury

Who gets to use the title 'doctor'?

focus

focus

focus

leisure time